Tous Actualités
Suivre
Abonner AstraZeneca GmbH

AstraZeneca GmbH

More Choice for More Women

San Antonio, Texas (ots/PRNewswire)

  • 'The Latest Hormonal Treatment Options in the Breast Cancer Continuum'
  • An AstraZeneca Sponsored Webcast From the 2004 San Antonio Breast Cancer Symposium
This webcast will announce key new data for 'FASLODEX' and
'ARIMIDEX' that is being presented at the 27th San Antonio Breast
Cancer Symposium (SABCS), 8 - 11 December.
The webcast explores the latest developments in the treatment of
postmenopausal women with early and advanced and will be your
opportunity to...
  • Hear the world's leading breast cancer experts Professor Jeffrey Tobias and Professor Raimund Jakesz reviewing results from new studies examining hormonal treatment intervention strategies across the breast cancer treatment continuum
  • Understand what impact these study results will have on patients and on clinical practice.
  • Understand how hormonal therapies treat patients effectively and enable patients to have a better quality of life
  • Understand why patients need to receive the best therapy at the earliest point in their treatment.
To view and listen to the presentations, you can access the
webcast from 07.00 hrs CST, on Saturday 11 December 2004
via www.astrazenecapressoffice.com where a link will take you
to the webcast
Press materials will also be available on
www.astrazenecapressoffice.com
If you have not already done so, you will need to register on
www.AstraZenecaPressOffice.com prior to viewing the webcast. The
registration is simple, quick and immediately following registration
you will be provided with a password for future access. You will need
to use this password when accessing the webcast and presentations on
the website.
Telephone Interviews
Should you wish to interview the presenters, other lead
investigators or AstraZeneca spokespeople then please contact Lisa O'
Sullivan on +44(0)207-471-1500 or email:
lisa.o'sullivan@shirehealthinternational.com

Contact:

If you have any questions regarding access to the webcast please do
not hesitate to contact Nici Virley on +44(0)207-471-1500 or email:
nici.virley@shirehealthinternational.com who will be pleased to
assist you.

Plus de actualités: AstraZeneca GmbH
Plus de actualités: AstraZeneca GmbH